News

Whole-plant hemp proposals: what happens next for CBD?

Exporting unlicensed controlled medicines from the UK involves overlapping MHRA, Home Office and overseas rules with no clear single pathway.

a no holds barred interview with the CTA and GCS

MCCS Publishes New Standardised Dosing Guide

Cannabis based products for medicinal use in humans (CBPMs)